The sum to be paid out to shareholders for 2012 totals RON70 million.
Terapia is 96.7% controlled by Indian group Ranbaxy, which will receive dividends worth over EUR15 million. The remaining 3.3% of the company is owned by several individuals and legal entities.
Terapia Ranbaxy will also disburse unpaid dividends for 2011. Total dividends for 2011 amount to RON112.5 million.
The gross dividend for last year is 38% lower than that for the previous year, of RON0.45 per share.
Ranbaxy Laboratories, the largest medicine producer in India, bought a 96.7% stake in Terapia Cluj-Napoca in March 2006 from investment fund Advent International for $324 million. In 2008, Japanese pharmaceutical company Daiichi Sankyo became majority shareholder of Ranbaxy Laboratories.
Terapia plans investments worth some EUR10 million in 2013 and wants to increase sales by 10%.
The company registered sales of RON450 million in 2012, up 7% on the year. (EUR1=RON4.417)